274 related articles for article (PubMed ID: 25823713)
1. Activation of the Prostaglandin E2 receptor EP2 prevents house dust mite-induced airway hyperresponsiveness and inflammation by restraining mast cells' activity.
Serra-Pages M; Torres R; Plaza J; Herrerias A; Costa-Farré C; Marco A; Jiménez M; Maurer M; Picado C; de Mora F
Clin Exp Allergy; 2015 Oct; 45(10):1590-600. PubMed ID: 25823713
[TBL] [Abstract][Full Text] [Related]
2. The PGE2-EP2-mast cell axis: an antiasthma mechanism.
Torres R; Picado C; de Mora F
Mol Immunol; 2015 Jan; 63(1):61-8. PubMed ID: 24768319
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous prostaglandin E(2) restrains airway mast cell activity in vivo and reduces lung eosinophilia and Th(2) cytokine overproduction in house dust mite-sensitive mice.
Herrerias A; Torres R; Serra M; Marco A; Roca-Ferrer J; Picado C; de Mora F
Int Arch Allergy Immunol; 2009; 149(4):323-32. PubMed ID: 19295236
[TBL] [Abstract][Full Text] [Related]
4. Mast cell-dependent IL-33/ST2 signaling is protective against the development of airway hyperresponsiveness in a house dust mite mouse model of asthma.
Zoltowska Nilsson AM; Lei Y; Adner M; Nilsson GP
Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L484-L492. PubMed ID: 29146574
[TBL] [Abstract][Full Text] [Related]
5. The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma.
Zoltowska AM; Lei Y; Fuchs B; Rask C; Adner M; Nilsson GP
Clin Exp Allergy; 2016 Mar; 46(3):479-90. PubMed ID: 26609909
[TBL] [Abstract][Full Text] [Related]
6. PGE
Rastogi S; Willmes DM; Nassiri M; Babina M; Worm M
J Allergy Clin Immunol; 2020 Dec; 146(6):1387-1396.e13. PubMed ID: 32407837
[TBL] [Abstract][Full Text] [Related]
7. Activity of the cyclooxygenase 2-prostaglandin-E prostanoid receptor pathway in mice exposed to house dust mite aeroallergens, and impact of exogenous prostaglandin E2.
Herrerias A; Torres R; Serra M; Marco A; Pujols L; Picado C; de Mora F
J Inflamm (Lond); 2009 Oct; 6():30. PubMed ID: 19878559
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation.
Kay LJ; Yeo WW; Peachell PT
Br J Pharmacol; 2006 Apr; 147(7):707-13. PubMed ID: 16432506
[TBL] [Abstract][Full Text] [Related]
9. Locally administered prostaglandin E2 prevents aeroallergen-induced airway sensitization in mice through immunomodulatory mechanisms.
Torres R; Herrerias A; Serra-Pagès M; Marco A; Plaza J; Costa-Farré C; Montoya M; Picado C; de Mora F
Pharmacol Res; 2013 Apr; 70(1):50-9. PubMed ID: 23298698
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT
Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281
[TBL] [Abstract][Full Text] [Related]
11. Mast cell-derived serotonin enhances methacholine-induced airway hyperresponsiveness in house dust mite-induced experimental asthma.
Mendez-Enriquez E; Alvarado-Vazquez PA; Abma W; Simonson OE; Rodin S; Feyerabend TB; Rodewald HR; Malinovschi A; Janson C; Adner M; Hallgren J
Allergy; 2021 Jul; 76(7):2057-2069. PubMed ID: 33486786
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 inhibits mast cell-dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor.
Säfholm J; Manson ML; Bood J; Delin I; Orre AC; Bergman P; Al-Ameri M; Dahlén SE; Adner M
J Allergy Clin Immunol; 2015 Nov; 136(5):1232-9.e1. PubMed ID: 25962903
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E₂ suppresses allergic sensitization and lung inflammation by targeting the E prostanoid 2 receptor on T cells.
Zasłona Z; Okunishi K; Bourdonnay E; Domingo-Gonzalez R; Moore BB; Lukacs NW; Aronoff DM; Peters-Golden M
J Allergy Clin Immunol; 2014 Feb; 133(2):379-87. PubMed ID: 24075232
[TBL] [Abstract][Full Text] [Related]
14. Allergin-1 on mast cells suppresses house dust mite-induced airway hyperresponsiveness in mice.
Hitomi K; Tahara-Hanaoka S; Miki H; Iwata K; Shibayama S; Kubo M; Shibuya A
Int Immunol; 2018 Aug; 30(9):429-434. PubMed ID: 30169732
[TBL] [Abstract][Full Text] [Related]
15. Complement factor C5 inhibition reduces type 2 responses without affecting group 2 innate lymphoid cells in a house dust mite induced murine asthma model.
Yang J; Ramirez Moral I; van 't Veer C; de Vos AF; de Beer R; Roelofs JJTH; Morgan BP; van der Poll T
Respir Res; 2019 Jul; 20(1):165. PubMed ID: 31340811
[TBL] [Abstract][Full Text] [Related]
16. Proteinase-activated receptor-2 activation participates in allergic sensitization to house dust mite allergens in a murine model.
Davidson CE; Asaduzzaman M; Arizmendi NG; Polley D; Wu Y; Gordon JR; Hollenberg MD; Cameron L; Vliagoftis H
Clin Exp Allergy; 2013 Nov; 43(11):1274-85. PubMed ID: 24152160
[TBL] [Abstract][Full Text] [Related]
17. Effects of sublingual immunotherapy in a murine asthma model sensitized by intranasal administration of house dust mite extracts.
Shima K; Koya T; Tsukioka K; Sakagami T; Hasegawa T; Fukano C; Ohashi-Doi K; Watanabe S; Suzuki E; Kikuchi T
Allergol Int; 2017 Jan; 66(1):89-96. PubMed ID: 27397923
[TBL] [Abstract][Full Text] [Related]
18.
Plaza J; Torres R; Urbano A; Picado C; de Mora F
Allergy Asthma Immunol Res; 2020 Jul; 12(4):712-728. PubMed ID: 32400135
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandins E2 signal mediated by receptor subtype EP2 promotes IgE production in vivo and contributes to asthma development.
Gao Y; Zhao C; Wang W; Jin R; Li Q; Ge Q; Guan Y; Zhang Y
Sci Rep; 2016 Feb; 6():20505. PubMed ID: 26852804
[TBL] [Abstract][Full Text] [Related]
20. Vaccination against IL-33 Inhibits Airway Hyperresponsiveness and Inflammation in a House Dust Mite Model of Asthma.
Lei Y; Boinapally V; Zoltowska A; Adner M; Hellman L; Nilsson G
PLoS One; 2015; 10(7):e0133774. PubMed ID: 26214807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]